OTCMKTS:ESLOY EssilorLuxottica (ESLOY) Stock Price, News & Analysis $100.56 0.00 (0.00%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock About EssilorLuxottica Stock (OTCMKTS:ESLOY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EssilorLuxottica alerts:Sign Up Key Stats Today's Range$100.13▼$101.5650-Day Range$97.59▼$126.0352-Week Range$96.56▼$186.81Volume60,431 shsAverage Volume113,759 shsMarket Capitalization$93.18 billionP/E RatioN/ADividend Yield1.68%Price TargetN/AConsensus RatingBuy Company Overview EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses. The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames. Notable lens technologies and brands developed by the legacy Essilor business include progressive and specialty lenses as well as photochromic and anti-reflective coatings, while the legacy Luxottica business is known for iconic frame and sunglass brands such as Ray-Ban and Oakley. EssilorLuxottica also operates optical retail chains and e-commerce sites, supplying branded and private-label products through chains and independent eyecare professionals and managing after-sales services and optical labs. EssilorLuxottica serves customers worldwide, with operations and sales across Europe, the Americas, Asia-Pacific, the Middle East and Africa. The company emphasizes investment in R&D, omnichannel retailing and partnerships with eye care professionals to address global vision needs, including prescription correction and sun protection. The business is led by an executive team drawn from the combined company; Francesco Milleri serves as Chief Executive Officer, overseeing strategy that integrates manufacturing, brand management and retail distribution across global markets.AI Generated. May Contain Errors. Read More EssilorLuxottica Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreESLOY MarketRank™: EssilorLuxottica scored higher than 48% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.7 / 5Analyst RatingBuy Consensus RatingEssilorLuxottica has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 5 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageEssilorLuxottica has only been the subject of 1 research reports in the past 90 days.Read more about EssilorLuxottica's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth16.13% Earnings GrowthEarnings for EssilorLuxottica are expected to grow by 16.13% in the coming year, from $4.34 to $5.04 per share.Price to Earnings Growth RatioEssilorLuxottica has a PEG Ratio of 1.64. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEssilorLuxottica has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about EssilorLuxottica's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of EssilorLuxottica has been sold short.Short Interest Ratio / Days to CoverEssilorLuxottica has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in EssilorLuxottica has recently increased by 295.27%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldEssilorLuxottica pays a meaningful dividend of 1.68%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthEssilorLuxottica does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, EssilorLuxottica will have a dividend payout ratio of 33.53% next year. This indicates that EssilorLuxottica will be able to sustain or increase its dividend.Read more about EssilorLuxottica's dividend. News and Social Media3.6 / 5News Sentiment0.72 News SentimentEssilorLuxottica has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for EssilorLuxottica this week, compared to 2 articles on an average week.Search Interest1 people have searched for ESLOY on MarketBeat in the last 30 days. MarketBeat Follows4 people have added EssilorLuxottica to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EssilorLuxottica insiders have not sold or bought any company stock.Percentage Held by Institutions0.01% of the stock of EssilorLuxottica is held by institutions.Read more about EssilorLuxottica's insider trading history. Receive ESLOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EssilorLuxottica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ESLOY Stock News HeadlinesThe Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind (ESLOY)Alphabet and Samsung's entry into smart glasses signals a hardware supercycle, challenging Meta's early market lead with EssilorLuxottica.May 24 at 8:30 AM | marketbeat.comEssilorLuxottica (OTCMKTS:ESLOY) Stock Crosses Below 50-Day Moving Average - Time to Sell?May 21, 2026 | americanbankingnews.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.May 25 at 1:00 AM | Profits Run (Ad)EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Receives Average Recommendation of "Buy" from BrokeragesMay 17, 2026 | americanbankingnews.comEssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026May 12, 2026 | globenewswire.comEssilorLuxottica considered investing in Amplifon in the past, CEO saysApril 28, 2026 | reuters.comEssilorLuxottica slips as doubts linger over smart glasses growthApril 23, 2026 | reuters.comEssilorLuxottica posts 3rd straight quarter of double-digit growthApril 23, 2026 | investing.comSee More Headlines ESLOY Stock Analysis - Frequently Asked Questions How have ESLOY shares performed this year? EssilorLuxottica's stock was trading at $158.42 at the beginning of 2026. Since then, ESLOY shares have decreased by 36.5% and is now trading at $100.56. Does EssilorLuxottica have any subsidiaries? The following companies are subsidiaries of EssilorLuxottica: Future Vision, Brille24, Union Optic, MOA, Indulentes, Spectera, Expert Optics, and more. How do I buy shares of EssilorLuxottica? Shares of ESLOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/25/2026Next Earnings (Estimated)7/28/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryPersonal Services Current SymbolOTCMKTS:ESLOY CIK1085922 Webwww.essilorluxottica.com Phone(314) 977-4224Fax33-1-49-77-43-24Employees203,791Year Founded2018Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E Ratio23.17 P/E Growth1.64Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.17 Current Ratio0.99 Quick Ratio0.70 Sales & Book Value Annual Sales$32.23 billion Price / Sales2.89 Cash Flow$7.65 per share Price / Cash Flow13.14 Book Value$48.22 per share Price / Book2.09Miscellaneous Outstanding Shares926,580,000Free FloatN/AMarket Cap$93.18 billion OptionableNot Optionable Beta0.94 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:ESLOY) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EssilorLuxottica Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share EssilorLuxottica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.